June 4, 2024
CellCarta offers a full range of validated proteomic assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team of experts will guide and customize multiplexed assays to meet clinical trial needs, recommending the most appropriate path to validate assays, single plex and mutliplex.
Contact us for any custom development or assay validation.
You might also be interested by
Case Studies & Whitepapers
Development of a personalized digital biomarker of vaccine-associated reactogenicity using wearable sensors and digital twin technology
April 21, 2025
More infoPosters
Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials
April 7, 2025
More infoPosters
Beyond Affinity: Simplifying ADC quantitation without compromising sensitivity.
April 7, 2025
More info